Recognized standard
E2865-12 (Reapproved 2022)
FDA recognition 18-6 · ASTM · Nanotechnology
Key facts
| Recognition number | 18-6 |
|---|---|
| Designation | E2865-12 (Reapproved 2022) |
| Title | Standard Guide for Measurement of Electrophoretic Mobility and Zeta Potential of Nanosized Biological Materials |
| Standards developer | ASTM International |
| Specialty area | Nanotechnology |
| Date of entry | Jan 14, 2019 |
| Scope (excerpt) | 1.1 This guide deals with the measurement of mobility and zeta potential in systems containing biological material such as proteins, DNA, liposomes and other similar organic materials that possess particle s in the nanometer scale (<100 nm). 1.2 The values stated in SI units are to be regarded as… |
At a glance
- None Product codes
- 1–9 FDA guidance documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-recognized consensus standards
The FDA recognizes voluntary consensus standards that manufacturers can cite in premarket submissions to show conformity with specific requirements.
Source: U.S. Food and Drug Administration (FDA), Recognized Consensus Standards database · Source date: